Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [AI's 'Next Wave' of Stocks]( [Click here to see which AI stock he believes could be next]( --------------------------------------------------------------- December 19, 2023 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?]( little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming. [See what this potential vanadium hotspot could mean to investors.]( --------------------------------------------------------------- [Ocular Therapeutix]( Ticker: [OCUL]( Recent Price: $3.67 Average Analyst Price Target: $12.00 (241.06%) Market Cap: $312.12M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 1,538,461 $4,999,998 2 Days Ago Recent Analyst Action: Colleen M., analyst at Robert W. Baird, reiterates coverage on [Ocular Therapeutix (OCUL)]( in the Healthcare sector with a Buy rating and a price target of $18 (1 week ago). Here are 3rd party ratings for [OCUL](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 30% (64 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Rare Chance to Be an Early Investor in AI Energy Breakthrough]( expert Ian King has found a way to invest in the technology powering AI energy. A breakthrough that presents a once-in-a-lifetime opportunity for fast-acting investors. [Just go here for full details.]( --------------------------------------------------------------- [Liquidia Technologies]( Ticker: [LQDA]( Recent Price: $7.47 Average Analyst Price Target: $13.60 (65.17%) Market Cap: $509.56M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 279,330 $2,000,003 2 Days Ago Director, >10% Owner, Other Informative Buy Non Open Market Buy 1,117,318 $7,999,997 6 Days Ago Recent Analyst Action: Julian Harrison, analyst at BTIG, reiterates coverage on [Liquidia Technologies (LQDA)]( in the Healthcare sector with a Buy rating and a price target of $18 (2 weeks ago). Here are 3rd party ratings for [LQDA](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Top 24% (58 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Abbott Labs]( Ticker: [ABT]( Recent Price: $108.06 Average Analyst Price Target: $120.40 (9.62%) Market Cap: $186.26B Role Transaction Description No. of Shares Amount Date EVP Informative Buy Non Open Market Buy 15,000 $666,000 2 Days Ago Recent Analyst Action: Larry Biegelsen, analyst at Wells Fargo, reiterates coverage on [Abbott Labs (ABT)]( in the Healthcare sector with a Buy rating and a price target of $121 (5 days ago). Here are 3rd party ratings for [ABT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Bottom 43% (144 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Electromed]( Ticker: [ELMD]( Recent Price: $10.63 Average Analyst Price Target: $20.50 (144.59%) Market Cap: $88.82M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 28,797 $302,369 2 Days Ago Recent Analyst Action: Brooks O'Neil, analyst at Lake Street, reiterates coverage on [Electromed (ELMD)]( in the Healthcare sector with a Buy rating and a price target of $26 (1 month ago). Here are 3rd party ratings for [ELMD](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: hold - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Vestis Corporation]( Ticker: [VSTS]( Recent Price: $19.56 Average Analyst Price Target: $20.80 (9.05%) Market Cap: ― Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 10,370 $200,627 2 Days Ago Recent Analyst Action: Seth Weber, analyst at Wells Fargo, reiterates coverage on [Vestis Corporation (VSTS)]( in the Industrials sector with a Buy rating and a price target of $24 (4 days ago). Here are 3rd party ratings for [VSTS](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Hold, Bottom 29% (178 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Prepare for the Next Wave of AI Stocks]( Almost every investor has heard of Nvidia. The AI chipmaker became the 7th trillion-dollar company in history. It’s up 233% this year alone …...9,624% over the last decade. Here’s the exciting thing about investing in AI: [Nvidia was just the beginning.]( Over the next few months, I expect a new wave of AI stocks to take the lead. Some could soar even higher than Nvidia. [Click here to find out which three AI stocks I think have the most potential.]( --------------------------------------------------------------- [Tellurian]( Ticker: [TELL]( Recent Price: $0.74 Average Analyst Price Target: $2.23 (-45.62%) Market Cap: $431.76M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 120,000 $80,400 2 Days Ago Recent Analyst Action: Benjamin Nolan, analyst at Stifel Nicolaus, reiterates coverage on [Tellurian (TELL)]( in the Energy sector with a Sell rating and a price target of $0.4 (1 month ago). Here are 3rd party ratings for [TELL](: - TipRanks.com: Moderate Sell - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 34% (70 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [American Homes]( Ticker: [AMH]( Recent Price: $35.93 Average Analyst Price Target: $37.40 (3.98%) Market Cap: $12.87B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 2,000 $48,620 2 Days Ago Recent Analyst Action: Brad Heffern, analyst at RBC Capital, reiterates coverage on [American Homes (AMH)]( in the Real Estate sector with a Buy rating and a price target of $39 (5 days ago). Here are 3rd party ratings for [AMH](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 40% (152 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Billionaires Are Now FLOODING Into Gold]( Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5). [Click here for the No. 1 gold recommendation.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software